Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Albuminuria in patients with Systemic Lupus Erythematous
Vol 5, Issue 1, 2024
VIEWS - 129 (Abstract)
Download PDF
Abstract
Renal involvement is one of the main causes of morbidity and mortality in patients with Systemic Lupus Erythematous. Lupus Nephropathy should be detected early. Albuminuria may be the only finding in the early stage of kidney disease. An observational, descriptive and retrospective study was carried out to determine the presence of Albuminuria (> 30 mg/24 h) in 60 patients with SLE who were admitted to the Rheumatology Service of the “10 de Octubre” Surgical Clinical Hospital, between October 2013 and September 2014. Albuminuria was observed to increase with increasingly pronounced drops in Glomerular Filtration (predicted according to the equation used in the MDRD Study). A significant statistical association was also obtained between albuminuria and disease evolution time: the longer the disease evolution time, the greater the albuminuria observed. Albuminuria is frequent in patients with SLE, its values being directly proportional to the time of evolution of the disease. This did not occur with the Glomerular Filtration, which remained relatively constant for any time of disease evolution.
Keywords
References
1. Rivera F, Romera AM, Villabón P, et al. Systemic lupus erythematosus. Lupus nephropathy. Available online: https://www.nefrologiaaldia.org/es-articulo-lupus-eritematoso-sistemico-nefropatia-lupica—263 (accessed on 13 January 2024).
2. Navarrete CL, Ibáñez C. Role of Apoptosis in the Pathophysiology of Systemic Lupus Erythematosus. Rev Chilena Reumatol. 2008; 24(1): 30–38.
3. Hernández Y, Brizuelas L, Hernández C. Late-onset lupus. Case presentation. Rev. Cub Reumatol. 2012; 14(19): 3–12.
4. Reyes Llerena Gil A. Community prevalence of rheumatic diseases and associated disability [PhD thesis]. MINSAP; 2004.
5. Benitez VN. An autoimmune disease that is difficult to manage: Case Analysis. Available online: https://repositorio.usfq.edu.ec/bitstream/23000/8687/1/144504.pdf (accessed on 13 January 2023).
6. Mussano E, Onetti L, Cadile I, et al. Systemic lupus erythematosus: sociodemographic data and its clinical-analytical correlation in a university hospital. Available online: https://www.scielo.org.ar/scielo.php?pid=S2362-36752019000400002&script=sci_arttext (accessed on 13 January 2024).
7. Guibert Toledano M, Reyes Llerena G, Hernández Martínez A, Torres Carballeira R. Measurement of Lupus activity in patients with Systemic Lupus Erythematosus. Cuban Rev. of Reumatol. 2000; II(1): 4–11.
8. Perl A, Fernandez D, Telarico T, et al. Endogenous retroviral pathogenesis in lupus. Current Opinion in Rheumatology. 2010; 22(5): 483–492. doi: 10.1097/bor.0b013e32833c6297
9. Carvajal C. Proteinuria and microalbuminuria. Rev Med leg Costa Rica. 2017; 34(1).
10. López SM, López JA, Montenegro LP, et al. Laboratory analysis for early diagnosis of chronic kidney failure. Rev Mex Urol. 2019; 78(1).
11. Gainza de los Ríos FJ. Acute Kidney Failure. Available online: https://www.nefrologiaaldia.org/317 (accessed on 4 April 2024).
12. Treviño BA, Baca ER, Meza CC, et al. Comparative glomerular filtration measurement by cystatin C and conventional methods based on creatinine clearance. Rev Hosp Jua Mex. 2010; 77(1): 22–7.
13. JC lasted. Systemic lupus erythematosus. In Clinical Rheumatology. Spain: Elsevier; 2010. pp. 163–78.
14. González D, Mejía S, Cruz M. Systemic lupus erythematosus: general approach to the disease. Rev Med Sinergia. 2021; 6(1): 1–17.
15. Rojas JE, Praga M. Lupus Nephropathy. Systemic lupus erythematosus. Available online: https://www.nefrologiaaldia.org/589 (accessed on 9 April 2024).
16. Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol. 2000; 11: A0828.
17. Huidobro EJP, Tagle R, Guzmán AM. Creatinine and its use for the estimation of glomerular filtration rate. Revista médica de Chile. 2018; 146(3): 344–350. doi: 10.4067/s0034-98872018000300344
18. Munguía C, Paniagua JR. Biomarkers in chronic kidney disease. Rev Med Ins Mex Seg Soc. 2017; 55(2).
19. Shahjahan YR, Amin MM, Khan M, et al. Correlation of Beta 2 microglobulin with Serum Creatinine and Creatinine Clearance in patients with different levels of renal function. J Med Sci. 2011; 9(2): 178–82.
20. Rivera F, Anaya S, Romera AM. Clinical Syndromes in Nephrology. Available online: https://www.nefrologiaaldia.org/es-articulo-sindromes-clinicos-nefrologia-258 (accessed on 11 April 2024).
21. Castellanos Y, Fong JA, Vázquez JM, Oliva J. Markers of kidney damage in patients with risk factors for chronic kidney disease. MEDISAN. 2018; 22(2): 142–8.
22. Hemmelgarn BR. Relation Between Kidney Function, Proteinuria, and Adverse Outcomes. JAMA. 2010; 303(5): 423. doi: 10.1001/jama.2010.39
23. Herrera Y, Menéndez ML, Serra MA. Microalbuminuria as a marker of kidney damage in patients with arterial hypertension. Rev habancienc méd. 2019; 18(2).
24. Hinojosa GI, Paramio A. Microalbuminuria in the early diagnosis of kidney damage in diabetic patients. Rev Finlay. 2021; 11(2).
25. Farías F, Páez N, Acosta E, et al. Correlation between protein/creatinine ratio and 24-hour proteinuria in patients with kidney disease. Acta Bioquím Clín Latinoam. 2015; 49(2): 215–20.
26. García R, Bover J, Segura J, et al. Information and consensus document for the detection and management of chronic kidney disease. Rev nefrol. 2022; 42(3): 223–362.
27. Montañés R, Bover J, Oliver A, et al. Assessment of the new CKD-EPI equation for estimating glomerular filtration rate. Available online: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952010000200007 (accessed on 12 April 2024).
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 María Elena Corrales Vázquez, Silvia María Pozo Abreu, Elena Caridad Megret Vidal, José Pedro Martínez Larrarte
License URL: https://creativecommons.org/licenses/by/4.0/
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
.png)
Prof. Wei-Yen Hsu
National Chung Cheng University, Taiwan
